ACET Earnings & Financial Statements
Adicet Bio, Inc.
$4.89
-$0.22(-4.31%)
33
Overall
60
Value
9
Tech
31
Quality
Market Cap
$45.78M
Volume
357.76K
52W Range
$5.55 - $17.44
Target Price
$34.83
ACET earnings and financial statements: Adicet Bio, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
ACET Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | - | $727.0K | $714.0K | $24.99M | $9.73M |
| Operating income | -$122.11M | -$127.61M | -$152.04M | -$72.55M | -$61.43M |
| EBITDA | -$110.39M | -$110.65M | -$136.53M | -$67.14M | -$60.41M |
| Net income | -$116.80M | -$117.12M | -$142.66M | -$69.79M | -$62.00M |
| EPS (diluted) | $-16.95 | $-21.28 | $-52.96 | $-27.20 | $-32.00 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $192.35M | $220.22M | $207.29M | $330.69M | $338.94M |
| Total liabilities | $33.15M | $33.61M | $37.12M | $38.35M | $35.81M |
| Shareholders’ equity | $159.21M | $186.61M | $170.18M | $292.34M | $303.13M |
| Cash and equivalents | $38.92M | $56.49M | $159.71M | $257.66M | $277.54M |
| Long-term debt | $11.55M | $14.10M | $17.70M | $18.53M | $19.38M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$95.25M | -$92.38M | -$93.72M | -$44.77M | -$51.05M |
| Capital expenditure | -$1.74M | -$1.12M | -$4.46M | -$16.78M | -$13.05M |
| Free cash flow | -$96.98M | -$93.50M | -$98.18M | -$61.55M | -$64.10M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ACET | $4.89 | -4.3% | 357.76K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |